ArticleEuropean radiology experimental2026
Disorganized bone collagen fibers in early-stage type 2 diabetes mellitus and its association with adipose tissue redistribution.
Article in European radiology experimental, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectiveType 2 diabetes mellitus (T2DM) compromises bone quality and biomechanical integrity, driven by impaired microstructure, suppressed turnover, and collagen abnormalities. Crucially, this fragility occurs despite normal bone mineral density and may initiate early in the disease, underscoring the need for timely skeletal assessment. MATERIALS AND
methodsTwelve male Sprague-Dawley rats were randomly assigned to either the control or the T2DM group. Within 2 weeks of model confirmation, all underwent dual-energy x-ray absorptiometry, in vivo magnetic resonance imaging of the liver and femur, and blood collection for comprehensive biochemical and lipid profiling. Subsequently, all right femurs were harvested for micro-computed tomography, biomechanical testing, and Masson's staining. The tibia and fibula were collected for the analysis of bone metabolism markers and advanced glycation end products (AGEs).
resultsCompared with the control group, T2DM rats exhibited higher body weight from week 10 onward, along with increased fat mass and body fat percentage. Serum total cholesterol, alanine aminotransferase and aspartate aminotransferase levels were elevated. Hepatic proton density fat fraction (PDFF) was higher. No intergroup differences of serum calcium, magnesium and phosphorus, cancellous/cortical bone and biomechanical testing parameters. Femoral collagen fiber organization was impaired in T2DM rats. Procollagen type I N-terminal propeptide was upregulated, while osteocalcin relative mRNA expression was downregulated. Femoral collagen organization was strongly negatively correlated with hepatic PDFF.
conclusionIn early-stage T2DM, bone damage follows a temporal sequence (organic before inorganic) and site-specific (pronounced in cancellous bone). These changes parallel systemic metabolic disturbances, and ameliorating adipose and hepatic dysfunction may help restore bone collagen matrix homeostasis. KEY POINTS: Question How does the metabolic microenvironment shaped by adipose tissue redistribution affect bone microarchitecture in patients with early-stage T2DM? Findings In early-stage T2DM, bone damage may exhibit a temporal (organic-first) and spatial (cancellous-predominant) pattern, and coexists particularly with abnormal lipid metabolism and hepatic dysfunction. Relevance statement In early-stage T2DM, abnormal lipid metabolism and liver function may serve as a potential indicator of compromised bone quality. Therapeutic interventions aimed at ameliorating adipose and hepatic dysfunction in T2DM may help restore bone collagen matrix homeostasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.